Becht R, Kielbowski K, Wasilewicz MP (2024) New opportunities in the systemic treatment of hepatocellular carcinoma-today and tomorrow. Int J Mol Sci 25(3):1456. https://doi.org/10.3390/ijms25031456

Article  CAS  PubMed  PubMed Central  Google Scholar 

Chang Y, Jeong SW, Young Jang J, Jae Kim Y (2020) Recent updates of transarterial chemoembolilzation in hepatocellular carcinoma. Int J Mol Sci 21(21):8165. https://doi.org/10.3390/ijms21218165

Article  CAS  PubMed  PubMed Central  Google Scholar 

Chen S, Zhao Z, Wang X, Zhang Q, Lyu L, Tang B (2022) The predictive competing endogenous RNA regulatory networks and potential prognostic and immunological roles of cyclin A2 in pan-cancer analysis. Front Mol Biosci 9:809509. https://doi.org/10.3389/fmolb.2022.809509

Article  CAS  PubMed  PubMed Central  Google Scholar 

Gu J, Liu X, Li J, He Y (2019) MicroRNA-144 inhibits cell proliferation, migration and invasion in human hepatocellular carcinoma by targeting CCNB1. Cancer Cell Int 19:15. https://doi.org/10.1186/s12935-019-0729-x

Article  PubMed  PubMed Central  Google Scholar 

Jin J, Xu H, Li W, Xu X, Liu H, Wei F (2020) LINC00346 acts as a competing endogenous RNA regulating development of hepatocellular carcinoma via modulating CDK1/CCNB1 axis. Front Bioeng Biotechnol 8:54. https://doi.org/10.3389/fbioe.2020.00054

Article  PubMed  PubMed Central  Google Scholar 

Kang TW, Rhim H (2015) Recent advances in tumor ablation for hepatocellular carcinoma. Liver Cancer 4:176–187. https://doi.org/10.1159/000367740

Article  CAS  PubMed  PubMed Central  Google Scholar 

Liu C, Yang S, Wang K, Bao X, Liu Y, Zhou S, Liu H, Qiu Y, Wang T, Yu H (2019) Alkaloids from Traditional Chinese Medicine against hepatocellular carcinoma. Biomed Pharmacother 120:109543. https://doi.org/10.1016/j.biopha.2019.109543

Article  CAS  PubMed  Google Scholar 

Liu J, Zhu X, Pan Y, Zhong J, Jin R, Zheng X, Zhang W, Hu K, Ma J, Shi X, Liu H, Yang X, Xu D, Ma C, Chen J, Wang D, Wang X, Li Z, Zhao L, Zhang L, Li T, Liu F, Tan G, Xing B, Zhao H, Zeng Y, Zhang S, Zhang L, Zhou L, Song T, Yang W, Liang X, Xiang B, Xu L, Sun H, Wang K (2024) Prognoses of patients treated with surgical therapy versus continuation of local-plus-systemic therapy following successful down-staging of intermediate-advanced hepatocellular carcinoma: a multicenter real-world study. Oncologist 29:e487–e497. https://doi.org/10.1093/oncolo/oyad277

Article  PubMed  Google Scholar 

Lu L, Han H, Tian Y, Li W, Zhang J, Feng M, Li Y (2015) Aurora kinase A mediates c-Myc’s oncogenic effects in hepatocellular carcinoma. Mol Carcinog 54:1467–1479. https://doi.org/10.1002/mc.22223

Article  CAS  PubMed  Google Scholar 

Ma YN, Jiang X, Song P, Tang W (2024) Neoadjuvant therapies in resectable hepatocellular carcinoma: exploring strategies to improve prognosis. Biosci Trends 18:21–41. https://doi.org/10.5582/bst.2023.01436

Article  CAS  PubMed  Google Scholar 

Nie Y, Yan J, Huang X, Jiang T, Zhang S (2024) Zhang G (2024) Dihydrotanshinone I targets ESR1 to induce DNA double-strand breaks and proliferation inhibition in hepatocellular carcinoma. Phytomedicine 130:155767. https://doi.org/10.1016/j.phymed.2024.155767

Article  CAS  PubMed  Google Scholar 

Shen Z, Yin L, Zhou H, Ji X, Jiang C, Zhu X, He X (2021) Combined inhibition of AURKA and HSF1 suppresses proliferation and promotes apoptosis in hepatocellular carcinoma by activating endoplasmic reticulum stress. Cell Oncol (dordr) 44:1035–1049. https://doi.org/10.1007/s13402-021-00617-w

Article  CAS  PubMed  Google Scholar 

Wang B, Hsu CJ, Chou CH, Lee HL, Chiang WL, Su CM, Tsai HC, Yang SF, Tang CH (2018) Variations in the AURKA gene: biomarkers for the development and progression of hepatocellular carcinoma. Int J Med Sci 15:170–175. https://doi.org/10.7150/ijms.22513

Article  CAS  PubMed  PubMed Central  Google Scholar 

Wang Y, Zhong Y, Zheng X, Cheng N, Yang Y, Yang Y, Wang F, Zhuang Q, Huang Y, Guo W, Liao N, Yang X, Zhao B, Liu X (2023) LncRNA TIALD contributes to hepatocellular carcinoma metastasis via inducing AURKA lysosomal degradation. Cell Death Discov 9:316. https://doi.org/10.1038/s41420-023-01620-w

Article  CAS  PubMed  PubMed Central  Google Scholar 

Xia P, Zhang H, Xu K, Jiang X, Gao M, Wang G, Liu Y, Yao Y, Chen X, Ma W, Zhang Z, Yuan Y (2021) MYC-targeted WDR4 promotes proliferation, metastasis, and sorafenib resistance by inducing CCNB1 translation in hepatocellular carcinoma. Cell Death Dis 12:691. https://doi.org/10.1038/s41419-021-03973-5

Article  CAS  PubMed  PubMed Central  Google Scholar 

Yang LY, He CY, Chen XH, Su LP, Liu BY, Zhang H (2016) Aurora kinase A revives dormant laryngeal squamous cell carcinoma cells via FAK/PI3K/Akt pathway activation. Oncotarget 7:48346–48359. https://doi.org/10.18632/oncotarget.10233

Article  PubMed  PubMed Central  Google Scholar 

Yu SJ (2023) Immunotherapy for hepatocellular carcinoma: recent advances and future targets. Pharmacol Ther 244:108387. https://doi.org/10.1016/j.pharmthera.2023.108387

Article  CAS  PubMed  Google Scholar 

Zhang P, Zhang D, Zhou W, Wang L, Wang B, Zhang T, Li S (2023) Network pharmacology: towards the artificial intelligence-based precision traditional Chinese medicine. Brief Bioinform 25(1):bbad518. https://doi.org/10.1093/bib/bbad518

Article  PubMed  Google Scholar